SEC Form 4 · accession 0000950138-18-000671
Express Scripts Holding Co. · ESRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maura C Breen
Director
Period of report
Dec 20, 2018
Accepted (ET)
Dec 21, 2018 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001532063
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 20, 2018 | D | 27,305 | $0.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy)F3,F2 | $52.53 | Dec 20, 2018 | D | 6,870 | D | — | May 30, 2019 | Express Scripts Holding Company Common Stock | 6,870 | 0 | D |
| Non-Qualified Stock Option (Right to Buy)F3,F2 | $61.58 | Dec 20, 2018 | D | 5,872 | D | — | May 9, 2020 | Express Scripts Holding Company Common Stock | 5,872 | 0 | D |
| Non-Qualified Stock Option (Right to Buy)F3,F2 | $67.05 | Dec 20, 2018 | D | 6,402 | D | — | May 7, 2021 | Express Scripts Holding Company Common Stock | 6,402 | 0 | D |
| Non-Qualified Stock Option (Right to Buy)F3,F2 | $84.08 | Dec 20, 2018 | D | 5,604 | D | — | May 6, 2025 | Express Scripts Holding Company Common Stock | 5,604 | 0 | D |
| Non-Qualified Stock Option (Right to Buy)F3,F2 | $72.74 | Dec 20, 2018 | D | 7,032 | D | — | May 4, 2026 | Express Scripts Holding Company Common Stock | 7,032 | 0 | D |
| Non-Qualified Stock Option (Right to Buy)F3,F2 | $60.66 | Dec 20, 2018 | D | 8,006 | D | — | May 11, 2027 | Express Scripts Holding Company Common Stock | 8,006 | 0 | D |
Explanation of responses
- F1Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement.
- F2The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
- F3Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.